ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

WSJ BLOG/Health: A.M. Vitals: U.S. Officials Defend Testing Regime for Mad Cow Disease

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.) By Mark Long Here's what's making health news this morning: U.S. Defends Safety of Nation's Beef (WSJ): Officials said the testing regimen for mad cow disease is effective and that a diseased cow found in California was never a threat to the food supply, after Indonesia suspended U.S. beef imports. Cuomo Aims to Salvage Health Pact (WSJ): Doctors led by private-practice specialists in and around New York City fear the governor's effort to overhaul out-of-network medical charges will fall apart without legislation to impose price controls on insurers, while health plans say this would make out-of-network care less affordable. Exposure to Violence in Children Harms DNA, Study Says (Los Angeles Times): Duke University researchers found in a long-term study of 118 pairs of twins published in Molecular Psychiatry that boys and girls exposed to violence had shorter telomeres -- the strands of DNA that cap chromosomes. Shortened telomeres have been linked to susceptibility to disease. CDC: Airline Passenger Didn't Have Monkeypox (Associated Press): Officials said a woman's rash wasn't related to the disease, after passengers on a Delta flight from Detroit were kept from disembarking in Chicago for about three hours. FDA Rejects Amgen's Application for Xgeva (Reuters): The risks of expanding use of the osteoporosis drug to delay the spread of bone tumors in patients with advanced prostate cancer was deemed to outweigh the effect of the proposed new application. AstraZeneca CEO Leaving as Profits Slide (WSJ): David Brennan announced he will retire in June as the U.K. drug maker posted a 44% drop in first-quarter profit. Allscripts Plunges After Chairman, Three Directors Leave (Bloomberg News): The electronic-health-records provider fired its chairman after the board "engaged in extensive deliberations" about company leadership, prompting the three directors who disagreed to quit. -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
05/10/201311:47:11Medicare Overpaid $529 Million for Anemia Drugs in 2011 - Report
05/09/201317:50:29Amgen Forms China Joint Venture
05/09/201317:39:11Amgen Forms China Joint Venture With Zhejiang Beta Pharma
05/07/201317:40:22Amgen Trial of Colon Cancer Drug Meets Goal
05/07/201317:29:37Amgen Late-Stage Trial of Colon Cancer Drug Meets Goal
04/29/201315:04:16Regeneron Pharmaceuticals Co-Founder Receives $81.55 Million...
04/26/201309:42:31As Biotechnology Stocks Soar, Bubble Talk Percolates
04/24/201309:04:55U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
04/23/201319:00:18Amgen Sales Disappoint as Profits Jump 21%
04/23/201316:50:54Amgen First-Quarter Profit Up 21%; Prolia Sales Leap
04/23/201313:11:46MARKET SNAPSHOT: Apple, Caterpillar: Shocked Stocks Get New Test
04/18/201313:08:13Merck CEO Pay Rises but Still Nicked by Research Setbacks
04/16/201317:30:14Amgen to Pay $24.9 Million to Settle Kickbacks Allegations
04/16/201317:23:12Amgen to Pay $24.9 Million to Settle U.S. Allegations of Kickbacks
03/20/201311:03:57Model N Shares Rise After IPO
02/27/201311:20:08U.S. Supreme Court Rejects Amgen Challenge to Suit
02/27/201310:48:32U.S. Supreme Court Rejects Amgen Challenge to Securities Suit
02/26/201314:07:10FDA Stops Pediatric Studies of Amgen's Sensipar After Death
02/14/201312:25:30Affymax Shares Fall as Customer Pauses Pilot Drug Program
02/07/201308:51:11Amgen Raises 2013 Earnings View on Tax-Charge Adjustment

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad